Webinar: Empowering Breast Health: Personalized Approaches to Canadian Breast Cancer Screening

Posted September 14, 2023

Dr. Jennifer Brooks webinar poster, showcasing personalized approaches to Canadian breast cancer screening
October 19, 2023
12:00 pm
to 1:00 pm

About the webinar

Did you know that Canadian women face a 1 in 8 chance of developing breast cancer in their lifetime and that it is the most common cancer and the second leading cause of cancer death? Join Dr. Jennifer Brooks, our incoming Executive Director, for a highly anticipated webinar on breast cancer awareness and prevention in Canada. Breast cancer is a significant health concern in Canada, affecting countless lives and families. As we strive for progress, we must understand its complexities, manage risks effectively, and enhance our screening strategies. Whether you’re a researcher seeking advancements or someone who has experienced breast cancer firsthand, this webinar offers a unique opportunity to engage with the latest insights, connect with like-minded individuals, and contribute to the ongoing effort to improve breast cancer awareness, prevention, and management in Canada.

About the presenter

Dr. Jennifer Brooks headshot, researcher integrating epidemiologic, genetic, clinical, imaging, and administrative health data to study breast cancer risk, and survivorship.
Dr. Jennifer Brooks

Dr. Jennifer Brooks is an Associate Professor of Epidemiology at the Dalla Lana School of Public Health (DLSPH) at the University of Toronto. She completed her PhD in epidemiology at New York University and her post-doctoral fellowship at Memorial Sloan Kettering Cancer Center. Dr. Brooks is also the Acting Program Director for PhD students in Epidemiology at DLSPH and an Honorary Scientist at the Centre for Epidemiology and Biostatistics at the University of Melbourne, Australia. Her research integrates epidemiologic, genetic, clinical, imaging, and administrative health data to study breast cancer risk and survivorship. Specifically, her work seeks to apply risk prediction tools to inform breast cancer screening and prevention. She also studies the impact of breast cancer treatments on patient outcomes, including second primary contralateral breast cancer and treatment-related late effects.